MENU
+Compare
AGNPF
Stock ticker: OTC
AS OF
Aug 8 closing price
Price
$0.05
Change
+$0.01 (+25.00%)
Capitalization
1.39M

AGNPF Algernon Pharmaceuticals Inc. Forecast, Technical & Fundamental Analysis

Algernon Pharmaceuticals Inc is a clinical-stage drug development company focused on the disease areas of stroke, idiopathic pulmonary fibrosis, and chronic cough... Show more

AGNPF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for AGNPF with price predictions
Aug 08, 2025

AGNPF's RSI Indicator ascending out of oversold territory

The RSI Oscillator for AGNPF moved out of oversold territory on July 24, 2025. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 33 similar instances when the indicator left oversold territory. In of the 33 cases the stock moved higher. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Moving Average Convergence Divergence (MACD) for AGNPF just turned positive on July 24, 2025. Looking at past instances where AGNPF's MACD turned positive, the stock continued to rise in of 58 cases over the following month. The odds of a continued upward trend are .

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where AGNPF advanced for three days, in of 162 cases, the price rose further within the following month. The odds of a continued upward trend are .

AGNPF may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 64 cases where AGNPF's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

The Momentum Indicator moved below the 0 level on August 07, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on AGNPF as a result. In of 109 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The 50-day moving average for AGNPF moved below the 200-day moving average on July 14, 2025. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where AGNPF declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for AGNPF entered a downward trend on August 01, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.044) is normal, around the industry mean (18.662). P/E Ratio (2.221) is within average values for comparable stocks, (54.033). AGNPF's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.909). Dividend Yield (0.000) settles around the average of (0.049) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (286.048).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to slightly better than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. AGNPF’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. AGNPF’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
AGNPF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
601 West Broadway
Phone
+1 604 398-4175
Employees
N/A
Web
https://www.algernonpharmaceuticals.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
KEY17.610.20
+1.15%
KeyCorp
SRBK14.020.12
+0.86%
SR Bancorp
ALRM54.410.07
+0.13%
Alarm.com Holdings
MSN0.44N/A
-0.05%
Emerson Radio Corp
XYF13.58-0.51
-3.62%
X Financial

AGNPF and Stocks

Correlation & Price change

A.I.dvisor tells us that AGNPF and CGEN have been poorly correlated (+23% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that AGNPF and CGEN's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AGNPF
1D Price
Change %
AGNPF100%
+13.58%
CGEN - AGNPF
23%
Poorly correlated
+4.17%
CYDY - AGNPF
21%
Poorly correlated
-1.72%
VIVS - AGNPF
21%
Poorly correlated
-0.11%
ABCZF - AGNPF
10%
Poorly correlated
N/A
KYMR - AGNPF
8%
Poorly correlated
-0.56%
More